InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Reed Elizabeth e, General Secretary. Officer active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 33 disclosures have been published. Breakdown: 0 buy · 13 sells. Total volume traded: €2.3m. History available since 11 May 2021. The latest transaction was filed on 15 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Reed Elizabeth e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
14,000 shares0Common StockSEC:0001283303-26-000008:0
10,000 shares@ US$19.080.0034% mcap6.1% of flowCommon StockSEC:0001283303-26-000008:1
20,000 shares@ US$17.960.0065% mcap11.5% of flowCommon StockSEC:0001283303-26-000008:2
7,500 shares@ US$15.460.0021% mcap3.7% of flowCommon StockSEC:0001283303-26-000008:3
37,500 shares@ US$41.070.028% mcap49.2% of flowCommon StockSEC:0001283303-26-000008:4
7,215 shares@ US$41.92880.0054% mcap9.7% of flowCommon StockSEC:0001283303-26-000008:5
5,226 shares@ US$41.620.0039% mcap6.9% of flowCommon StockSEC:0001283303-26-000008:6
1,559 shares@ US$42.530.0012% mcap2.1% of flowCommon StockSEC:0001283303-26-000008:7
10,000 shares@ US$15.464.5% of flowCommon StockSEC:0001283303-26-000007:0
10,000 shares@ US$30.008.7% of flowCommon StockSEC:0001283303-26-000007:1
10,000 shares@ US$19.085.3% of flowCommon StockSEC:0001283303-26-000006:0
10,000 shares@ US$19.084.4% of flowCommon StockSEC:0001283303-26-000005:0
2,485 shares@ US$32.071.8% of flowCommon StockSEC:0001283303-26-000003:0
25,110 shares0Common StockSEC:0001283303-26-000002:0
10,000 shares@ US$19.084.4% of flowCommon StockSEC:0001283303-26-000001:0
10,000 shares@ US$19.084.9% of flowCommon StockSEC:0001283303-25-000005:0
4,920 sharesCommon StockSEC:0001415889-25-012054:0
8,000 sharesCommon StockSEC:0001415889-25-003823:0
21,500 shares0Common StockSEC:0001415889-25-003066:0
2,437 shares@ US$19.4616.0% of flowCommon StockSEC:0001415889-25-002004:0
6,750 shares0Common StockSEC:0001415889-24-023095:0
25,000 shares0Common StockSEC:0001415889-24-002283:0
2,062 shares@ US$8.966.0% of flowCommon StockSEC:0001415889-24-001801:0
3,300 shares0Common StockSEC:0001209191-23-048256:0
825 shares@ US$16.594.4% of flowCommon StockSEC:0001209191-23-029012:0
25 of 33 declarations
About Reed Elizabeth e
REED ELIZABETH E is Vice-Présidente, Conseillère Juridique et Secrétaire Général, and Chief Legal Officer and GC at Travere Therapeutics, Inc. She has 33 filings in total, and in the recent filings tracked, the activity consists of disposals, with EUR 0 of purchases and EUR 2337576 of sales between 2021-05-13 and 2026-04-15.
